Clinical trial
The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow…
NCT00336115 · Queen Elizabeth II Health Sciences Centre, Other · Unknown status
Key facts
| NCT number | NCT00336115 |
|---|---|
| Title | The Safety and Immunogenicity of Acellular Pertussis Vaccine in Bone Marrow Transplant Recipients |
| Official title | Safety and Immunogenicity of Adult Formulation Tetanus and Diphtheria Toxoids Adsorbed Combined With Acellular Pertussis (Tdap) Vaccine Following Blood and Morrow Transplantation in Adults |
| Lead sponsor | Queen Elizabeth II Health Sciences Centre, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Pertussis |
| Intervention type | Biological |
| Interventions | Tetanus and Diphtheria Toxoids Adsorbed Combined with Acellular Pertussis (Adacel) |
| Enrollment | 10 |
| Start date | Jul 1, 2006 |
| Completion | May 1, 2008 |
| First posted | Jun 12, 2006 |
| Last update posted | Oct 23, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: